Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by yorgosGKon Apr 10, 2018 4:09pm

134 Views

Post# 27861946

LEVEL 2 At the close

As of right now, we have a wide open road to the .30's again. Its perfectly setup that way. Everyone sees the M-arc changing a trend. The sales that knocked us down today are laughable....noobs just leaving.

We look fanTASTIC at the close....We absorbed a lot of bears today! We had almost 7M of total Sell Vol at the start of the day. We chipped away to only 4.6M remaining, which most are just BS sell orders through the levels. Will be interesting to see the market depth tomorrow AM.

Will be a very interesting week. You can almost bet your bottom dollar we will be back at the top of the arc in time for some news to take us to new future heights. I trust KALY & Rob. Cheers gang.

User image